Blocking the PI3K/AKT and MEK/ERK signaling pathways can overcome Gefitinib-resistance in non-small cell lung cancer cell linesH Li, Caicun Zhou, Xiaoyu Yang et al.|Advances in Medical Sciences|2011Cited by 85